Cleared Traditional

K220959 - OR3O Dual Mobility System

K220959 is the FDA 510(k) clearance for OR3O Dual Mobility System by Smith & Nephew, Inc.. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 139-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
139d
Days
Class 2
Risk

K220959 is an FDA 510(k) clearance for the OR3O Dual Mobility System. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Cordova, US). The FDA issued a Cleared decision on August 18, 2022 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K220959 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2022
Decision Date August 18, 2022
Days to Decision 139 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 122d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 439
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K220959.
ONVOY Acetabular System
K213842 · Globus Medical, Inc. · Oct 2022
Mg-PSZ Ceramic Femoral Head
K220336 · Theken Companies · Sep 2022
EMPHASYS Acetabular System
K221636 · Depuy Ireland UC · Sep 2022
My3D® Personalized Pelvic Reconstruction
K212815 · Onkos Surgical · Jul 2022
Smith & Nephew Hip Systems
K211176 · Smith & Nephew, Inc. · Jul 2022
DePuy 3D Additive TriFlange Acetabular Cup
K201348 · Depuy International, Ltd. · Jun 2022